🔎 Trials Near Me

Gara Jalqabaatti › Lymphoma Follicular › New York › New York City

Qorannoo klinikaalii Lymphoma Follicular New York City, NY keessatti

Qorannoo 24 Lymphoma Follicular f New York City fi naannoo isaa (kilomeetira 30 keessatti) hirmaatuu jiru. Qorannoo banaa eenyu akka hirmaatu fi akkamitti garee qorannoo akka quunnaman ilaali.

Takkalaa qorannoo (Ingiliffa)

Qorannoo hirmaatuu barbaadduu? Fuula kana jalatti agarsiisi — $99 guyyaa 30f →

A Dose-Escalation and Expansion Study of Tacabrutideg (BGB-16673) in Participants With B-Cell Malignancies

Namoota walitti qabaa jiraSadarkaa 1/2
  • Columbia University Medical Center, New York
  • Weill Cornell Medical College Newyork Presbyterian Hospital, New York
  • Memorial Sloan Kettering Cancer Center Mskcc, New York
Umuriin 18 fi ol · Saalaa hunda · Haaromfame 05-Onk-2026 · NCT05006716

Testing Addition of an Anti-cancer Drug, Vorasidenib to Temozolomide, After Radiation for Advanced Brain Cancer

Namoota walitti qabaa jiraSadarkaa 3
  • Laura and Isaac Perlmutter Cancer Center at NYU Langone, New York
  • NYP/Columbia University Medical Center/Herbert Irving Comprehensive Cancer Center, New York
  • Memorial Sloan Kettering Cancer Center, New York
Umuriin 12 fi ol · Saalaa hunda · Haaromfame 02-Onk-2026 · NCT07215910

A Study to Evaluate Safety, PK, PD and Efficacy of AZD5492, a T Cell-engaging Antibody Targeting CD20 in Subjects With R/R B-Cell Malignancies.

Namoota walitti qabaa jiraSadarkaa 1/2
  • Research Site, New York
  • Research Site, New York
Umuriin 18 fi ol · Saalaa hunda · Haaromfame 30-Ful-2026 · NCT06542250

Epco, Zanu, Ritux for R/R FL or MZL

Namoota walitti qabaa jiraSadarkaa 2
  • Memorial Sloan Kettering Cancer Center, New York
Umuriin 18 fi ol · Saalaa hunda · Haaromfame 25-Ful-2026 · NCT06563596

A Study of LY4152199 in Participants With Previously Treated B-cell Malignancies (BAF_FRontier-1 )

Namoota walitti qabaa jiraSadarkaa 1
  • New York University (NYU) Clinical Cancer Center, New York
  • Weill Cornell Medicine, New York
  • David H. Koch Center for Cancer Care at Memorial Sloan Kettering Cancer Center, New York
Umuriin 18 fi ol · Saalaa hunda · Haaromfame 22-Ful-2026 · NCT07101328

A Study of Debio 0123 in Combination With Temozolomide in Adult Participants With Recurrent or Progressive Glioblastoma and of Debio 0123 in Combination With Temozolomide and Radiotherapy in Adult Participants With Newly Diagnosed Glioblastoma

Namoota walitti qabaa jiraSadarkaa 1/2
  • New York University Langone Medical Center, New York
  • David H. Koch Center for Cancer Care at Memorial Sloan Kettering Cancer Center, New York
Umuriin 18 fi ol · Saalaa hunda · Haaromfame 22-Ful-2026 · NCT05765812

A Study of LY4584180 in Adult Participants With Previously Treated Blood Cancers

Namoota walitti qabaa jiraSadarkaa 1
  • Columbia University, New York
Umuriin 18 fi ol · Saalaa hunda · Haaromfame 22-Ful-2026 · NCT07226843

A Study of Surovatamig (AZD0486) Plus Rituximab in Previously Untreated Follicular Lymphoma Patients

Namoota walitti qabaa jiraSadarkaa 3
  • Research Site, New York
  • Research Site, New York
  • Research Site, New York
Umuriin 18 hanga 130 · Saalaa hunda · Haaromfame 21-Ful-2026 · NCT06549595

Surovatamig (AZD0486) as Monotherapy in Participants With Relapsed/Refractory (R/R) B-cell NHL

Namoota walitti qabaa jiraSadarkaa 2
  • Research Site, New York
Umuriin 18 fi ol · Saalaa hunda · Haaromfame 11-Ful-2026 · NCT06526793

Study to Evaluate the Efficacy and Safety of [177Lu]Lu-DOTA-TATE in Patients With Grade 1 and Grade 2 Advanced GEP-NET

Namoota walitti qabaa jiraSadarkaa 3
  • Mount Sinai Medical Center, New York
Umuriin 12 hanga 100 · Saalaa hunda · Haaromfame 11-Ful-2026 · NCT06784752

A Trial to Learn if Odronextamab is Safe and Well-Tolerated and How Well it Works Compared to Rituximab Combined With Different Types of Chemotherapy for Adult Participants With Previously Untreated Follicular Lymphoma

Namoota walitti qabaa jiraSadarkaa 3
  • Icahn School of Medicine at Mt Sinai, New York
Umuriin 18 fi ol · Saalaa hunda · Haaromfame 11-Ful-2026 · NCT06091254

Testing the Addition of an Anti-Cancer Drug, Triapine, to the Usual Radiation Therapy for Recurrent Glioblastoma or Astrocytoma

Namoota walitti qabaa jiraSadarkaa 1
  • Laura and Isaac Perlmutter Cancer Center at NYU Langone, New York
  • NYP/Columbia University Medical Center/Herbert Irving Comprehensive Cancer Center, New York
Umuriin 18 fi ol · Saalaa hunda · Haaromfame 02-Ful-2026 · NCT06860594

SIGMA (Safusidenib in IDH1 Mutant Glioma Maintenance)

Namoota walitti qabaa jiraSadarkaa 3
  • NYU Langone Health, New York
  • Icahn School of Medicine at Mount Sinai, New York
  • Columbia University Medical Center, New York
  • fi 1 dabalataa
Umuriin 18 fi ol · Saalaa hunda · Haaromfame 28-Hag-2026 · NCT05303519

A Study of ARC-02 in B-cell NHL

Namoota walitti qabaa jiraSadarkaa 1
  • NYU Langone, New York
Umuriin 18 fi ol · Saalaa hunda · Haaromfame 26-Hag-2026 · NCT07691606

Study of Rondecabtagene Autoleucel in Aggressive Large B-Cell Lymphoma

Namoota walitti qabaa jiraSadarkaa 1/2
  • David H. Koch Center for Cancer Care at Memorial Sloan Kettering Cancer Center, New York
Umuriin 18 fi ol · Saalaa hunda · Haaromfame 25-Hag-2026 · NCT05826535

rTMS and Cognitive-behavioral Therapy for Cocaine Use Disorder

Namoota walitti qabaa jira
  • New York State Psychiatric Institute (NYSPI) / Substance Treatment and Research Service (STARS), New York
Umuriin 22 hanga 65 · Saalaa hunda · Haaromfame 17-Hag-2026 · NCT05974202

A Study of Mosunetuzumab Alone or With Zanubrutinib in People With Follicular Lymphoma

Namoota walitti qabaa jiraSadarkaa 2
  • Memorial Sloan Kettering Cancer Center, New York
Umuriin 18 fi ol · Saalaa hunda · Haaromfame 10-Hag-2026 · NCT05389293

This is a Phase 1 Study to Evaluate the Safety of LTZ-301 in Patients With Non-Hodgkin Lymphoma

Namoota walitti qabaa jiraSadarkaa 1
  • Memorial Sloan Kettering Cancer Center - Bergen, New York
Umuriin 18 fi ol · Saalaa hunda · Haaromfame 24-Ado-2026 · NCT07121946

Chronic CED of TPT for Recurrent Malignant Glioma

Namoota walitti qabaa jiraSadarkaa 1
  • Columbia University Irving Medical Center / NewYork-Presbyterian Hospital, New York
Umuriin 18 fi ol · Saalaa hunda · Haaromfame 15-Wax-2026 · NCT06666712

Epcoritamab and Rituximab for First-line Follicular Lymphoma

Namoota walitti qabaa jiraSadarkaa 2
  • Icahn School of Medicine at Mount Sinai Hospital, New York
Umuriin 18 fi ol · Saalaa hunda · Haaromfame 22-Cam-2026 · NCT05783609

Epcoritamab in Patients With Follicular Lymphoma Not Accomplishing a CR With Upfront Chemoimmunotherapy

Namoota walitti qabaa jiraSadarkaa 2
  • Icahn School of Medicine at Mount Sinai, New York
Umuriin 18 fi ol · Saalaa hunda · Haaromfame 13-Bit-2026 · NCT06510361

A Study of Reduced Dose Radiation Therapy for People With B-Cell Lymphomas

Namoota walitti qabaa jiraSadarkaa 3
  • Memorial Sloan Kettering Cancer Center (All Protocol Activities), New York
Umuriin 18 fi ol · Saalaa hunda · Haaromfame 17-Gur-2026 · NCT07029217

Study of SGR-1505 in Mature B-Cell Neoplasms

Namoota walitti qabaa jiraSadarkaa 1
  • Weill Cornell, New York
Umuriin 18 fi ol · Saalaa hunda · Haaromfame 13-Gur-2026 · NCT05544019

SYNERGY-AI: Artificial Intelligence Based Precision Oncology Clinical Trial Matching and Registry

Namoota walitti qabaa jiraQorannoo ilaalaa
  • Massive Bio SYNERGY-AI site, New York
Umuriin hundi · Saalaa hunda · Haaromfame 28-Onk-2025 · NCT03452774

Qorannoo Lymphoma Follicular magaalota biroo keessatti

Qorannoo biroo New York City keessatti

Kanneen ClinicalTrials.gov irraa argaman, daataa 06-Onk-2026 irratti argame. Qorannoon hundi isaa kan ofii qajeelfama qoodfannaa qaba; gareen qorannoo eenyu akka hirmaatu murteessa.